ConvaTec Group (OTCMKTS:CNVVY) Upgraded at Sanford C. Bernstein

Sanford C. Bernstein upgraded shares of ConvaTec Group (OTCMKTS:CNVVY) to a strong-buy rating in a research report report published on Wednesday morning,Zacks.com reports.

Separately, Peel Hunt upgraded shares of ConvaTec Group from a “moderate buy” rating to a “strong-buy” rating in a research note on Tuesday, October 28th. Two research analysts have rated the stock with a Strong Buy rating, Based on data from MarketBeat, ConvaTec Group presently has a consensus rating of “Strong Buy”.

ConvaTec Group Stock Performance

Shares of OTCMKTS:CNVVY opened at $12.64 on Wednesday. The business has a fifty day moving average price of $12.70 and a 200-day moving average price of $12.77. ConvaTec Group has a 1-year low of $11.57 and a 1-year high of $16.65.

ConvaTec Group Company Profile

ConvaTec Group is a global medical products and technologies company focused on developing therapies and technologies for the management of chronic health conditions. The company’s portfolio spans four core business areas—Advanced Wound Care, Ostomy Care, Continence & Critical Care, and Infusion Devices—which are designed to improve patient outcomes and enhance quality of life for people living with long-term health challenges. ConvaTec’s product range includes proprietary wound dressings, ostomy and continence management systems, and safety-engineered infusion sets.

Headquartered in Reading, United Kingdom, ConvaTec serves customers in over 100 countries through a network of manufacturing, distribution, and customer support operations.